E
Evommune, Inc.
EVMN · NYSE · Healthcare · 532M
Closing price
$6.25
-2.50% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-2.3×
Free cash flow yieldFCF yield
-38.9%
Return on equityROE
-33.5%
Operating margin
-623.6%
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.